The Cigna Group (NYSE:CI) Shares Purchased by Savant Capital LLC

Savant Capital LLC raised its holdings in The Cigna Group (NYSE:CI) by 50.9% in the 2nd quarter, according to its most recent 13F filing with the SEC. The fund owned 17,375 shares of the health services provider’s stock after acquiring an additional 5,860 shares during the period. Savant Capital LLC’s holdings in The Cigna Group were worth $5,744,000 at the end of the most recent reporting period.

Other large investors also recently made changes to their positions in the company. Silicon Valley Capital Partners boosted its position in shares of The Cigna Group by 100.0% in the first quarter. Silicon Valley Capital Partners now owns 70 shares of the health services provider’s stock worth $25,000 after acquiring an additional 35 shares during the last quarter. Cedar Wealth Management LLC acquired a new position in shares of The Cigna Group in the 1st quarter valued at $29,000. Raleigh Capital Management Inc. boosted its holdings in shares of The Cigna Group by 69.5% in the 4th quarter. Raleigh Capital Management Inc. now owns 100 shares of the health services provider’s stock valued at $30,000 after purchasing an additional 41 shares during the last quarter. TruNorth Capital Management LLC purchased a new stake in shares of The Cigna Group during the 2nd quarter valued at $33,000. Finally, Pineridge Advisors LLC acquired a new stake in shares of The Cigna Group during the 4th quarter worth $37,000. Hedge funds and other institutional investors own 86.99% of the company’s stock.

Insider Buying and Selling at The Cigna Group

In other news, Director Elder Granger sold 547 shares of The Cigna Group stock in a transaction that occurred on Monday, June 17th. The stock was sold at an average price of $331.38, for a total value of $181,264.86. Following the completion of the transaction, the director now owns 5,471 shares in the company, valued at approximately $1,812,979.98. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. In other The Cigna Group news, Director Elder Granger sold 547 shares of The Cigna Group stock in a transaction on Monday, June 17th. The shares were sold at an average price of $331.38, for a total value of $181,264.86. Following the completion of the transaction, the director now owns 5,471 shares of the company’s stock, valued at $1,812,979.98. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, insider Brian C. Evanko sold 4,795 shares of the stock in a transaction on Monday, June 24th. The stock was sold at an average price of $345.01, for a total transaction of $1,654,322.95. Following the sale, the insider now directly owns 39,923 shares in the company, valued at $13,773,834.23. The disclosure for this sale can be found here. Insiders have sold 9,033 shares of company stock worth $3,095,820 over the last quarter. 0.60% of the stock is owned by corporate insiders.

The Cigna Group Stock Performance

Shares of CI opened at $353.49 on Friday. The firm has a market cap of $100.42 billion, a price-to-earnings ratio of 29.02, a PEG ratio of 1.10 and a beta of 0.50. The company has a quick ratio of 0.71, a current ratio of 0.71 and a debt-to-equity ratio of 0.73. The business’s 50 day moving average is $340.62 and its two-hundred day moving average is $343.61. The Cigna Group has a 52-week low of $253.95 and a 52-week high of $370.64.

The Cigna Group (NYSE:CI) last posted its quarterly earnings data on Thursday, August 1st. The health services provider reported $6.72 EPS for the quarter, beating analysts’ consensus estimates of $6.42 by $0.30. The firm had revenue of $60.52 billion for the quarter, compared to the consensus estimate of $58.30 billion. The Cigna Group had a net margin of 1.70% and a return on equity of 17.83%. The firm’s revenue was up 24.6% compared to the same quarter last year. During the same period in the prior year, the firm posted $6.13 EPS. Analysts forecast that The Cigna Group will post 28.5 EPS for the current fiscal year.

The Cigna Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, September 19th. Investors of record on Wednesday, September 4th will be issued a $1.40 dividend. This represents a $5.60 annualized dividend and a yield of 1.58%. The ex-dividend date is Wednesday, September 4th. The Cigna Group’s dividend payout ratio is currently 45.98%.

Analyst Upgrades and Downgrades

A number of equities research analysts have issued reports on the company. Baird R W raised The Cigna Group to a “strong-buy” rating in a research report on Thursday, May 30th. Cantor Fitzgerald reiterated an “overweight” rating and set a $400.00 target price on shares of The Cigna Group in a report on Monday, August 19th. Robert W. Baird assumed coverage on shares of The Cigna Group in a report on Thursday, May 30th. They issued an “outperform” rating and a $388.00 price target on the stock. Stephens reaffirmed an “overweight” rating and set a $410.00 price target on shares of The Cigna Group in a research report on Friday, August 2nd. Finally, JPMorgan Chase & Co. increased their price objective on shares of The Cigna Group from $435.00 to $438.00 and gave the stock an “overweight” rating in a research report on Wednesday, August 21st. One equities research analyst has rated the stock with a hold rating, thirteen have given a buy rating and two have given a strong buy rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Buy” and an average target price of $384.86.

The Cigna Group Company Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.